2024
Metabotropic Glutamate Receptor 5 as a Potential Biomarker of the Intersection of Trauma and Cannabis Use
Weiss E, Davis M, Asch R, D'Souza D, Cool R, Esterlis I. Metabotropic Glutamate Receptor 5 as a Potential Biomarker of the Intersection of Trauma and Cannabis Use. The International Journal Of Neuropsychopharmacology 2024, 27: pyae044. PMID: 39320043, DOI: 10.1093/ijnp/pyae044.Peer-Reviewed Original ResearchTrauma-related psychopathologyCannabis useDepressive symptomsPositron emission tomographyCross-diagnostic sampleMetabotropic glutamate receptor 5Treatment development effortsAssociated with depressive symptomsGlutamate receptor 5CU groupSample of individualsAvailability in vivoFrontolimbic regionsGlutamatergic systemGlutamatergic neurotransmissionMGlu5PsychopathologyReceptor 5Intersection of traumaExploratory analysisCannabisEmission tomographySymptomsParticipantsVmPFC
2016
Development and Initial Psychometric Evaluation of the Semi-Structured Emotion Regulation Interview
Lee DJ, Weathers FW, Sloan DM, Davis MT, Domino JL. Development and Initial Psychometric Evaluation of the Semi-Structured Emotion Regulation Interview. Journal Of Personality Assessment 2016, 99: 56-66. PMID: 27564399, DOI: 10.1080/00223891.2016.1215992.Peer-Reviewed Original ResearchConceptsSelf-report measuresEmotion Regulation InterviewInitial psychometric evaluationER strategiesEmotion typeStrategy useEmotion regulation strategy useER strategy useRegulation strategy usePsychometric evaluationClinician-administered measuresForms of psychopathologyConstruct validation frameworkTransdiagnostic predictorContent validity processExcellent discriminant validityDiscriminant validityValidity processFuture researchSevere anxietySubsequent interviewsMeasuresInterviewsAngerPsychopathology